Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenlu Chong

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Immunity|February 29, 2024
Oligoadenylate synthetase 1 displays dual antiviral mechanisms in driving translational shutdown and protecting interferon productionMunesh K Harioudh, Joseph Perez, Zhenlu Chong, et al.
Nature Communications|June 9, 2026
LRP4 is an entry receptor for multiple encephalitic alphavirusesSicheng Tian, Bingting Ma, Hongyuan Guo, et al.
Cell Reports. Medicine|December 1, 2023
A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protectionLucas J Adams, Laura A VanBlargan, Zhuoming Liu, et al.
Nature Communications|July 4, 2023
An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivoMoriya Tsuji, Manoj S Nair, Kazuya Masuda, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2025
LRP8 is an entry receptor for tick-borne encephalitis virusesPengfei Li, Sean Hui, Zhenlu Chong, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in miceBaoling Ying, Suzanne M Scheaffer, Bradley Whitener, et al.
Cell|March 10, 2021
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protectionEmma S Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.
Nature|October 30, 2025
Multiple LDLR family members act as entry receptors for yellow fever virusZhenlu Chong, Sean Hui, Xueer Qiu, et al.
Nature Communications|July 2, 2022
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strainsJames Brett Case, Samantha Mackin, John M Errico, et al.
Cell|April 22, 2022
Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in miceBaoling Ying, Suzanne M Scheaffer, Bradley Whitener, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Immunity|February 29, 2024
Oligoadenylate synthetase 1 displays dual antiviral mechanisms in driving translational shutdown and protecting interferon productionMunesh K Harioudh, Joseph Perez, Zhenlu Chong, et al.
Nature Communications|June 9, 2026
LRP4 is an entry receptor for multiple encephalitic alphavirusesSicheng Tian, Bingting Ma, Hongyuan Guo, et al.
Cell Reports. Medicine|December 1, 2023
A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protectionLucas J Adams, Laura A VanBlargan, Zhuoming Liu, et al.
Nature Communications|July 4, 2023
An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivoMoriya Tsuji, Manoj S Nair, Kazuya Masuda, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2025
LRP8 is an entry receptor for tick-borne encephalitis virusesPengfei Li, Sean Hui, Zhenlu Chong, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in miceBaoling Ying, Suzanne M Scheaffer, Bradley Whitener, et al.
Cell|March 10, 2021
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protectionEmma S Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.
Nature|October 30, 2025
Multiple LDLR family members act as entry receptors for yellow fever virusZhenlu Chong, Sean Hui, Xueer Qiu, et al.
Nature Communications|July 2, 2022
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strainsJames Brett Case, Samantha Mackin, John M Errico, et al.
Cell|April 22, 2022
Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in miceBaoling Ying, Suzanne M Scheaffer, Bradley Whitener, et al.
Pageof 3